The upcoming Supreme Court hearing on Braidwood Management v Becerra could affect how preventive services are covered by both public and private insurance.
Richard Hughes IV, JD, MPH, partner at Epstein Becker Green, discusses the implications of the Braidwood Management v Becerra case, which is being decided by the Supreme Court.
This transcript has been lightly edited; captions were auto-generated.
Transcript
What is the Braidwood v Becerra lawsuit and what does it affect?
So this is a case where the plaintiffs are challenging the requirement under the Affordable Care Act [ACA] to cover certain recommended preventive services. Initially they brought a set of constitutional claims, and they brought claims under the Religious Freedom Restoration Act. What the case before the Supreme Court really involves is the constitutional claims, and the remaining claims at this point are only related to the US Preventive Services Task Force.
What's in front of the court right now is the constitutionality of the role of the US Preventive Services Task Force in determining which services must be covered by health insurance plans in the United States, and this is a requirement that impacts not only all Americans who have private health insurance, but also applies directly to the individuals, the adults who also have Medicaid expansion coverage as well.
What are the major implications of the lawsuit when it comes to the ACA?
It is really another one of those significant Affordable Care Act cases, like we've seen in the past, but it's really the first that challenges the preventive services coverage requirement. So it's a really significant case when we think about access to preventive care in the United States. Before the Affordable Care Act, there was no requirement that commercial health insurance plans or Medicaid cover these types of preventive services. So it's definitely something that risks access for over 150 million Americans to recommended preventive care.
How might this lawsuit affect contraception and immunizations covered under the ACA?
So the question before the Supreme Court at this point in time does not involve the Advisory Committee on the Immunization Practices [ACIP], which recommends immunizations, or the recommendations by the Health Resources and Services Administration, or HRSA, which is where we see the contraceptive mandate. So immunizations, the contraceptive mandate, off the table before the court right now. I will say this was an issue that was raised at the lower court level. The plaintiffs did not want to have to cover certain recommended immunizations or contraceptives.
The lower court ruled in favor of the plaintiffs on the task force, but not with respect to immunizations and contraceptives. And so the lower court found that the way those bodies operate in determining coverage requirements under the ACA is constitutional, and so that's something that we could see come back up at a later date. Certainly the the plaintiffs did ask the Supreme Court to reconsider the constitutionality of the ACIP and HRSA roles. But for now, contraceptive mandate, immunizations off the table in this case. It's really focused on the US Preventive Services Task Force and required coverage of its recommendations.
Robert F. Kennedy Jr Faces Senate Inquiry Over Deep Cuts to HHS Impacting FDA, CDC, NIH, CMS
April 2nd 2025A bipartisan letter from lawmakers questions the legality of Robert F. Kennedy Jr's HHS changes and the lack of clear communication regarding their potential impact on American health.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More
Dermatologists Advocating for Inclusive Hair Loss Research and Treatment in the African Diaspora
March 26th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, advocates for increased funding and education to address hair loss disparities within the African diaspora, emphasizing the need for culturally sensitive treatment and research.
Read More